Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Van der Laan
PCN169 Differences in the Use of Innovative Anti-Cancer Drugs Among French Hospitals
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Prm112 - Incorporation of Anti-Cancer Drugs Adverse Events in Health Economic Opinions of the French National Authority for Health (Has)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Was It Worth Introducing Health Economic Evaluation of Innovative Drugs in the French Regulatory Setting? The Case of New Hepatitis C Drugs
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Target-Based Anti-Cancer Drugs
Drug Delivery System
Pharmaceutical Science
Ethics Codes and Use of New and Innovative Drugs
British Journal of Clinical Pharmacology
Pharmacology
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Breast Cancer Risk: Differences by Molecular Subtype
Cancer Causes and Control
Cancer Research
Oncology
Repurposed Anti-Cancer Drugs: The Future for Anti-Infective Therapy?
Expert Review of Anti-Infective Therapy
Virology
Infectious Diseases
Microbiology
Sex Differences in the Use of Asthma Drugs: Cross Sectional Study
BMJ
Aspects Regarding the Use of Drugs Among Athletes
Timisoara Physical Education and Rehabilitation Journal
Dna Damage Mechanisms of Anti-Cancer Drugs
Middle East Journal of Science
